​

Kiniksa Pharmaceuticals International (KNSA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Kiniksa Pharmaceuticals International Revenue Highlights

Latest Revenue (Y)

$677.56M

Latest Revenue (Q)

$285.97M

Main Segment (Y)

Product

Kiniksa Pharmaceuticals International Revenue by Period

Kiniksa Pharmaceuticals International Revenue by Year

DateRevenueChange
2025-12-31$677.56M60.09%
2024-12-31$423.24M56.60%
2023-12-31$270.26M22.74%
2022-12-31$220.18M471.24%
2021-12-31$38.54M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Kiniksa Pharmaceuticals International generated $677.56M in revenue during NA 2025, up 60.09% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Kiniksa Pharmaceuticals International Revenue by Quarter

DateRevenueChange
2026-09-30$285.97M17.39%
2026-06-30$243.60M13.69%
2026-03-31$214.27M6.01%
2025-12-31$202.13M11.76%
2025-09-30$180.85M15.34%
2025-06-30$156.80M13.80%
2025-03-31$137.78M12.44%
2024-12-31$122.54M9.20%
2024-09-30$112.21M3.30%
2024-06-30$108.63M36.03%
2024-03-31$79.86M-4.24%
2023-12-31$83.39M24.38%
2023-09-30$67.05M-6.19%
2023-06-30$71.47M47.84%
2023-03-31$48.34M-21.88%
2022-12-31$61.88M-37.58%
2022-09-30$99.14M267.55%
2022-06-30$26.97M-16.21%
2022-03-31$32.19M71.72%
2021-12-31$18.75M54.98%
2021-09-30$12.10M57.00%
2021-06-30$7.70M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Kiniksa Pharmaceuticals International generated $285.97M in revenue during Q3 2026, up 17.39% compared to the previous quarter, and up 182.38% compared to the same period a year ago.

Kiniksa Pharmaceuticals International Revenue Breakdown

Kiniksa Pharmaceuticals International Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22
Product$677.56M$417.03M$233.18M$122.52M
Collaboration-$6.21M$37.08M$97.66M

Kiniksa Pharmaceuticals International's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Product$285.97M$243.60M$214.27M$202.13M$180.85M$156.80M$137.78M$201.42M$112.21M$103.39M$136.02M$54.49M$42.66M$39.94M$33.42M$26.97M$22.19M
Collaboration--------$6.21M$5.24M$14.42M$16.98M$5.69M$21.95M---

Kiniksa Pharmaceuticals International's latest quarterly revenue breakdown by segment (product or service), as of Sep 26: Product (100.00%).

Kiniksa Pharmaceuticals International Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KNSAKiniksa Pharmaceuticals$677.56M$285.97M
PHARPharming Group$245.32M$55.46M
ANABAnaptysBio$234.60M$25.56M
NRIXNurix Therapeutics$83.98M$673.06M
ACRSAclaris Therapeutics$7.83M$1.48M
DNTHDianthus Therapeutics$2.04M-
AVTXAvalo Therapeutics$59.00K-
ORKAOruka Therapeutics--
SYRESpyre Therapeutics--
IMVTImmunovant-$7.09M

KNSA Revenue FAQ

What is Kiniksa Pharmaceuticals International’s yearly revenue?

Kiniksa Pharmaceuticals International's yearly revenue for 2025 was $677.56M, representing an increase of 60.09% compared to 2024. The company's yearly revenue for 2024 was $423.24M, representing an increase of 56.60% compared to 2023. KNSA's yearly revenue for 2023 was $270.26M, representing an increase of 22.74% compared to 2022.

What is Kiniksa Pharmaceuticals International’s quarterly revenue?

Kiniksa Pharmaceuticals International's quarterly revenue for Q3 2026 was $285.97M, a 17.39% increase from the previous quarter (Q2 2026), and a 58.12% increase year-over-year (Q3 2025). The company's quarterly revenue for Q2 2026 was $243.6M, a 13.69% increase from the previous quarter (Q1 2026), and a 55.36% increase year-over-year (Q2 2025). KNSA's quarterly revenue for Q1 2026 was $214.27M, a 6.01% increase from the previous quarter (Q4 2025), and a 55.51% increase year-over-year (Q1 2025).

What is Kiniksa Pharmaceuticals International’s revenue growth rate?

Kiniksa Pharmaceuticals International's revenue growth rate for the last 3 years (2023-2025) was 150.71%, and for the last 5 years (2021-2025) was 1657.90%.

What are Kiniksa Pharmaceuticals International’s revenue streams?

Kiniksa Pharmaceuticals International's revenue streams in c 25 are Product

What is Kiniksa Pharmaceuticals International’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Kiniksa Pharmaceuticals International was Product. This segment made a revenue of $677.56M, representing 100.00% of the company's total revenue.